Deglycosylated Anti-Aβ Antibody Dose–Response Effects on Pathology and Memory in APP Transgenic Mice

Ítems similars

• Deglycosylated Anti-Amyloid-β Antibodies Eliminate Cognitive Deficits and Reduce Parenchymal Amyloid with Minimal Vascular Consequences in Aged Amyloid Precursor Protein Transgenic Mice
  per: Wilcock, Donna M., et al.
  Publicat: (2006)
• Intracranial administration of deglycosylated C-terminal-specific anti-Aβ antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice
  per: Carty, Niki C, et al.
  Publicat: (2006)
• Suppression of Amyloid Deposition Leads to Long-Term Reductions in Alzheimer's Pathologies in Tg2576 Mice
  per: Karlnoski, Rachel A., et al.
  Publicat: (2009)
• Up-Regulation of Bcl-2 in APP Transgenic Mice is Associated with Neuroprotection
  per: Karlnoski, Rachel, et al.
  Publicat: (2006)
• Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage
  per: Wilcock, Donna M, et al.
  Publicat: (2004)